scispace - formally typeset
M

Murray N. Robertson

Researcher at Strathclyde Institute of Pharmacy and Biomedical Sciences

Publications -  20
Citations -  568

Murray N. Robertson is an academic researcher from Strathclyde Institute of Pharmacy and Biomedical Sciences. The author has contributed to research in topics: Binding site & In vivo. The author has an hindex of 13, co-authored 20 publications receiving 466 citations. Previous affiliations of Murray N. Robertson include University of Strathclyde & University of Sydney.

Papers
More filters
Journal ArticleDOI

Activity of Praziquantel Enantiomers and Main Metabolites against Schistosoma mansoni

TL;DR: Investigation of the in vitro activities of PZQ and its main metabolites confirmed that R-PZQ is the main effector molecule, while S-PzQ and the metabolites do not play a significant role in the antischistosomal properties of PzQ.
Journal ArticleDOI

Open Source Drug Discovery: Highly Potent Antimalarial Compounds Derived from the Tres Cantos Arylpyrroles.

TL;DR: One chemical subseries was found to exhibit oral activity but contained a labile ester that could not be replaced without loss of activity, and the original hit exhibited remarkable sensitivity to minor structural change.
Journal ArticleDOI

Open source drug discovery – A limited tutorial

TL;DR: Some straightforward steps others may wish to take towards more openness in their own research programmes are described, while existing and inexpensive online tools can solve many challenges.
Journal ArticleDOI

In vitro metabolic profile and in vivo antischistosomal activity studies of (η(6)-praziquantel)Cr(CO)3 derivatives.

TL;DR: In vitro metabolic behavior was investigated for two chromium tricarbonyl derivatives of the antischistosomal drug praziquantel with the formula (η(6)-PZQ)Cr(CO)3 (1 and 2), by use of human liver microsomes, where the R-enantiomers are highly active against adult schistosomes in vitro, whereas both S- enantiomers lack activity.